Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Therapeutic drug monitoring of mycophenolate sodium in lupus nephritis
ACTRN12611000798965Phase 3Recruiting
- Sponsor
- Royal Brisbane and Women's Hospital
- Start
- Sep 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of mycophenolate sodium in lupus nephritis (LN) and systemic lupus erythematosus (SLE), sponsored by Royal Brisbane and Women's Hospital. Started Sep 2011; status: recruiting.
02
Drugs
mycophenolate sodium
03
Conditions
lupus nephritis (LN)systemic lupus erythematosus (SLE)
Beyond the preview
Go deeper on ACTRN12611000798965.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12611000798965.